Hookipa Pharma Inc(HOOK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HOOK Hookipa Pharma Inc

交易中 04-19 10:09:37 EDT

0.7590

-0.0059

-0.77%

最高0.7999	最低0.7500	成交量5.23万
今开0.7500	昨收0.7649	日振幅6.52%
总市值7,510万	流通市值4,426万	总股本9,895万
成交额3.93万	换手率0.09%	流通股本5,831万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HOOK","market":"US","secType":"STK","nameCN":"Hookipa Pharma Inc","latestPrice":0.759,"timestamp":1713535744644,"preClose":0.7649,"halted":0,"volume":52278,"delay":0,"floatShares":58312594,"shares":98950107,"eps":-0.863037,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0059,"latestTime":"04-19 10:09:37 EDT","open":0.75,"high":0.7999,"low":0.75,"amount":39306.87883152,"amplitude":0.065237,"askPrice":0.759,"askSize":173,"bidPrice":0.755,"bidSize":301,"shortable":3,"etf":0,"ttmEps":-0.863037,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1713556800000},"adr":0,"listingDate":1555560000000,"adjPreClose":0.7649,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.747,"preClose":0.7649,"latestTime":"09:23 EDT","volume":20460,"amount":15421.299432,"timestamp":1713532995376},"postHourTrading":{"tag":"盘后","latestPrice":0.765,"preClose":0.7649,"latestTime":"19:53 EDT","volume":4025,"amount":3078.8899,"timestamp":1713484396683},"volumeRatio":0.92032},"requestUrl":"/m/hq/s/HOOK?invite=TIGER033","defaultTab":"news","newsList":[{"id":"2427006084","title":"Hookipa Pharma Inc.股价拉升14.43% 市值涨1285.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427006084","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427006084?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:44","pubTimestamp":1713188643,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时44分，Hookipa Pharma Inc.股票出现异动，股价急速上涨14.43%。截至发稿，该股报0.900美元/股，成交量8.5637万股，换手率0.09%，振幅18.56%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体涨幅为1.25%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152144037a52da8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152144037a52da8b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426800197","title":"Hookipa Pharma Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426800197","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426800197?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:42","pubTimestamp":1712929326,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时42分，Hookipa Pharma Inc.股票出现波动，股价大幅拉升5.44%。截至发稿，该股报0.849美元/股，成交量4.6158万股，换手率0.05%，振幅4.94%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122142067a52758a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122142067a52758a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425990851","title":"Hookipa Pharma Inc.盘中异动 大幅拉升5.12%报0.792美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425990851","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425990851?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:38","pubTimestamp":1712583534,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时38分，Hookipa Pharma Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报0.792美元/股，成交量10.6378万股，换手率0.11%，振幅2.65%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213855791f2c57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213855791f2c57&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421382930","title":"Hookipa Pharma Inc.2023财年实现净利润-81.58百万美元，同比减少25.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421382930","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421382930?lang=zh_cn&edition=full","pubTime":"2024-03-23 15:17","pubTimestamp":1711178249,"startTime":"0","endTime":"0","summary":"12月31日，Hookipa Pharma Inc.公布财报，公告显示公司2023财年净利润为-81.58百万美元，同比减少25.66%；其中营业收入为20.13百万美元，同比增加41.26%，每股基本收益为-0.86美元。从资产负债表来看，Hookipa Pharma Inc.总负债71.48百万美元，其中短期债务2.76百万美元，资产负债比为0.03，流动比率为0.04。机构评级：截至2023年12月31日，当前有4家机构对Hookipa Pharma Inc.目标价做出预测，其中目标均价为4.25美元，其中最低目标价为3.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032315173187aa9075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032315173187aa9075&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421890355","title":"BUZZ-Hookipa Pharma 全年收入增加，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2421890355","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421890355?lang=zh_cn&edition=full","pubTime":"2024-03-22 20:23","pubTimestamp":1711110199,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月22日 - ** 疗法开发商 Hookipa Pharma    股价盘前上涨 4.9% 至 76 美分** 公司在截至12月31日的12个月中的收入为2010万美元，去年同期为1420万美元** 截至2023年12月31日，Hookipa的现金及现金等价物为1.175亿美元，而截至2022年12月31日为1.134亿美元。** 截至上日收盘，股价累计下跌 10.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421945148","title":"HOOKIPA Pharma Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2421945148","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421945148?lang=zh_cn&edition=full","pubTime":"2024-03-22 19:41","pubTimestamp":1711107695,"startTime":"0","endTime":"0","summary":"   * HOOKIPA Pharma Inc   报告了截至12月底的季度调整后每股亏损22美分，低于去年同期的每股收益-17美分。* 营收同比下降 5.4%，至 741 万美元；分析师预期为 456 万美元。* HOOKIPA Pharma Inc公布的本季度每股收益为亏损22美分。* 该公司本季度亏损 2,482 万美元。* HOOKIPA Pharma Inc 本季度股价下跌了 10.6%。3月22日 - 预测变化   * 在过去三个月中，分析师的平均盈利预测上升了约 0.3%。* 华尔街对 HOOKIPA Pharma Inc 的 12 个月目标价中位数为 5.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420054794","title":"Hookipa Pharma Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420054794","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420054794?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:58","pubTimestamp":1710773932,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时58分，Hookipa Pharma Inc.股票出现波动，股价大幅跳水5.01%。截至发稿，该股报0.683美元/股，成交量12.7967万股，换手率0.13%，振幅4.49%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182258527a4d71f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182258527a4d71f8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419983428","title":"Hookipa Pharma Inc.盘中异动 早盘股价大跌6.16%报0.696美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419983428","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419983428?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:50","pubTimestamp":1710427800,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日22时50分，Hookipa Pharma Inc.股票出现异动，股价急速跳水6.16%。截至发稿，该股报0.696美元/股，成交量6.7211万股，换手率0.07%，振幅4.69%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314225000861de436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314225000861de436&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418352848","title":"HOOKIPA Pharma Inc    预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2418352848","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418352848?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:05","pubTimestamp":1710162310,"startTime":"0","endTime":"0","summary":"   * HOOKIPA Pharma Inc    预计将在3月13日公布截至2023年12月31日的业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于纽约的公司的营收预计将从去年同期的783万美元下降41.8%，至455.5万美元。* LSEG分析师对HOOKIPA Pharma公司的平均预期是每股亏损19美分。* 华尔街对HOOKIPA Pharma Inc的12个月目标价中位数为4.50美元，高于其最新收盘价0.76美元。3月11日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416144144","title":"Hookipa Pharma Inc.盘中异动 股价大涨6.47%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416144144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416144144?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:32","pubTimestamp":1709562764,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时32分，Hookipa Pharma Inc.股票出现异动，股价快速拉升6.47%。截至发稿，该股报0.820美元/股，成交量5.4128万股，换手率0.05%，振幅2.58%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240304223245861dafcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240304223245861dafcb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415137945","title":"Hookipa Pharma Inc盘中异动 早盘股价大涨5.22%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415137945","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415137945?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:24","pubTimestamp":1709133862,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日23时24分，Hookipa Pharma Inc股票出现波动，股价大幅拉升5.22%。Hookipa Pharma Inc股票所在的生物技术行业中，整体跌幅为0.26%。Hookipa Pharma Inc公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022823242279158ebf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022823242279158ebf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413214793","title":"Hookipa Pharma Inc盘中异动 股价大跌6.43%报0.614美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413214793","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413214793?lang=zh_cn&edition=full","pubTime":"2024-02-24 00:18","pubTimestamp":1708705082,"startTime":"0","endTime":"0","summary":"北京时间2024年02月24日00时18分，Hookipa Pharma Inc股票出现波动，股价急速跳水6.43%。Hookipa Pharma Inc股票所在的生物技术行业中，整体涨幅为0.56%。Hookipa Pharma Inc公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022400180287e72b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022400180287e72b4d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413422550","title":"Hookipa Pharma Inc盘中异动 股价大跌5.01%报0.632美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413422550","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413422550?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:14","pubTimestamp":1708528447,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日23时14分，Hookipa Pharma Inc股票出现异动，股价快速下挫5.01%。Hookipa Pharma Inc股票所在的生物技术行业中，整体涨幅为0.18%。Hookipa Pharma Inc公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221231407861d71af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221231407861d71af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411287391","title":"Hookipa Pharma Inc盘中异动 急速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411287391","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411287391?lang=zh_cn&edition=full","pubTime":"2024-02-14 04:18","pubTimestamp":1707855523,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日04时18分，Hookipa Pharma Inc股票出现异动，股价快速下跌5.20%。Hookipa Pharma Inc股票所在的生物技术行业中，整体跌幅为1.47%。Hookipa Pharma Inc公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214041843791145df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214041843791145df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409434858","title":"Hookipa Pharma Inc盘中异动 早盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409434858","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409434858?lang=zh_cn&edition=full","pubTime":"2024-02-05 23:59","pubTimestamp":1707148785,"startTime":"0","endTime":"0","summary":"北京时间2024年02月05日23时59分，Hookipa Pharma Inc股票出现波动，股价急速下挫5.13%。Hookipa Pharma Inc股票所在的生物技术行业中，整体涨幅为0.01%。Hookipa Pharma Inc公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402052359457a418348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402052359457a418348&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407801461","title":"美国研究综述-康泰伦特、Enphase Energy、F5","url":"https://stock-news.laohu8.com/highlight/detail?id=2407801461","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407801461?lang=zh_cn&edition=full","pubTime":"2024-01-30 15:15","pubTimestamp":1706598949,"startTime":"0","endTime":"0","summary":"    路透1月30日 - 华尔街证券分析师周二调整了对康泰伦特、Enphase Energy 和 F5 等几家美国上市公司的评级和目标价。公司要闻 * 康泰伦特  ：加拿大皇家银行将目标价从55美元上调至58美元 * Enphase Energy Inc   ：杰富瑞将目标价从145美元下调至126美元  * F5 Inc   ：Evercore ISI将目标价从180美元上调至200美元  * Masimo Corp   ：杰富瑞将目标价从 107 美元上调至 121 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407896994","title":"BUZZ-罗氏终止癌症治疗合作后，Hookipa 下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2407896994","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407896994?lang=zh_cn&edition=full","pubTime":"2024-01-29 23:50","pubTimestamp":1706543431,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月29日 - ** 疗法开发商Hookipa Pharma   股价下跌14.4%至59美分 ** 公司称已收到 (link) 罗氏  的通知，罗氏决定终止HOOK的HB-700疗法治疗KRAS突变癌症的合作和许可协议** HOOK公司将从罗氏公司重新获得HB-700的全球开发权** 公司计划于 2024 年第一季度提交开始 HB-700 临床","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2405085831","title":"Hookipa Pharma Inc盘中异动 快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405085831","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405085831?lang=zh_cn&edition=full","pubTime":"2024-01-24 01:45","pubTimestamp":1706031926,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日01时45分，Hookipa Pharma Inc股票出现波动，股价急速拉升5.08%。Hookipa Pharma Inc股票所在的生物技术行业中，整体涨幅为0.04%。Hookipa Pharma Inc公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124014526790b75dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124014526790b75dd&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hookipapharma.com","stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":0.0403},{"period":"3month","weight":0.1586},{"period":"6month","weight":0.613},{"period":"1year","weight":0.04},{"period":"ytd","weight":-0.0557}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"HOOKIPA Pharma Inc.于2017年2月根据特拉华州法律以Hookipa Biotech, Inc.的名义注册成立，是Hookipa Biotech AG的全资子公司。该公司是一家临床阶段的生物制药公司，开发基于专有沙粒病毒平台的新型免疫疗法，该平台旨在靶向和放大T细胞免疫反应以对抗疾病。该公司正在通过靶向癌病毒癌症抗原、自身抗原和下一代抗原，建立专有的免疫肿瘤学管道。该公司的肿瘤学产品组合包括三个已披露的项目，HB-200、HB-300和HB-700，它们都使用复制技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.081948},{"month":2,"riseRate":0.6,"avgChangeRate":0.127152},{"month":3,"riseRate":0.2,"avgChangeRate":-0.060883},{"month":4,"riseRate":0.8,"avgChangeRate":0.034304},{"month":5,"riseRate":0.8,"avgChangeRate":0.106534},{"month":6,"riseRate":0.2,"avgChangeRate":-0.196456},{"month":7,"riseRate":0.2,"avgChangeRate":-0.100672},{"month":8,"riseRate":0.4,"avgChangeRate":-0.021749},{"month":9,"riseRate":0.2,"avgChangeRate":-0.071488},{"month":10,"riseRate":0.2,"avgChangeRate":-0.085183},{"month":11,"riseRate":0.6,"avgChangeRate":0.054413},{"month":12,"riseRate":0.4,"avgChangeRate":0.014958}],"exchange":"NASDAQ","name":"Hookipa Pharma Inc","nameEN":"Hookipa Pharma Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hookipa Pharma Inc(HOOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hookipa Pharma Inc(HOOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hookipa Pharma Inc,HOOK,Hookipa Pharma Inc股票,Hookipa Pharma Inc股票老虎,Hookipa Pharma Inc股票老虎国际,Hookipa Pharma Inc行情,Hookipa Pharma Inc股票行情,Hookipa Pharma Inc股价,Hookipa Pharma Inc股市,Hookipa Pharma Inc股票价格,Hookipa Pharma Inc股票交易,Hookipa Pharma Inc股票购买,Hookipa Pharma Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hookipa Pharma Inc(HOOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hookipa Pharma Inc(HOOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}